# OnCo record nct02890602 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02890602/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02890602", "NCT02890602" ;
  schema:name "Erythropoietin for Management of Anemia Caused by Chemotherapy"@en ;
  schema:description "A phase 2 trial of Darbepoetin alfa, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone in Diffuse large B-cell lymphoma, run by Kosin University Gospel Hospital, completed."@en ;
  schema:url <https://onco.cc/trials/nct02890602/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02890602> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:drugs <https://onco.cc/drugs/darbepoetin-alfa/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/prednisone/> .